VenaSeal Closure System
Medtronic Vascular, Inc. · Decision date Oct 15, 2026
What did the FDA decide?
The FDA recorded a 30-Day Notice decision dated 2026-10-15 for P140018/S050, a supplement to the VenaSeal Closure System held by Medtronic Vascular, Inc. The listed device category is an occluding vascular agent intended to be permanent, with product code PJQ under the Cardiovascular specialty. The recorded statement covers approval for design, material, and manufacturing changes to components of the dispenser gun.
This action concerns the dispenser gun components rather than a new approval of the whole system, and the source does not identify which components changed, the nature of the design or material changes, or any supporting documents. The supplement reason is listed as a process change involving manufacturer, sterilizer, packager, or supplier. No clinical, performance, or labeling information accompanies the record, so the practical effect of the change cannot be assessed from this data alone.
FDA approval order statement
approval for design, material, and manufacturing changes to components of the dispenser gun
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 15, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P140018/S050
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic Vascular, Inc.
- Product code
- PJQ
- Decision code
- OK30
- Decision date
- Oct 15, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Agent, occluding, vascular, permanent.
- Applicant
- Medtronic Vascular, Inc.
- Product code
- PJQ
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P140018. Subsequent supplements may change the device or its indications.
FDA decision timeline
P140018 · Original PMA
VENASEAL CLOSURE SYSTEM
P140018/S050 received
Application receipt date recorded by FDA.
P140018/S050 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P140018. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P140018
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
VENASEAL CLOSURE SYSTEMP140018 | Medtronic Vascular, Inc. | PMA approval | Feb 20, 2015 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic Vascular, Inc.
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 3033 Campus Dr., Plymouth, MN, 55441
Sources and methodology
- Original FDA record: P140018/S050
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records